328 related articles for article (PubMed ID: 25588723)
1. Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.
Triscott J; Rose Pambid M; Dunn SE
Stem Cells; 2015 Apr; 33(4):1042-6. PubMed ID: 25588723
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
Triscott J; Lee C; Hu K; Fotovati A; Berns R; Pambid M; Luk M; Kast RE; Kong E; Toyota E; Yip S; Toyota B; Dunn SE
Oncotarget; 2012 Oct; 3(10):1112-23. PubMed ID: 23047041
[TBL] [Abstract][Full Text] [Related]
3. Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.
Lun X; Wells JC; Grinshtein N; King JC; Hao X; Dang NH; Wang X; Aman A; Uehling D; Datti A; Wrana JL; Easaw JC; Luchman A; Weiss S; Cairncross JG; Kaplan DR; Robbins SM; Senger DL
Clin Cancer Res; 2016 Aug; 22(15):3860-75. PubMed ID: 27006494
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells.
Liu P; Brown S; Goktug T; Channathodiyil P; Kannappan V; Hugnot JP; Guichet PO; Bian X; Armesilla AL; Darling JL; Wang W
Br J Cancer; 2012 Oct; 107(9):1488-97. PubMed ID: 23033007
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram Sensitizes a Therapeutic-Resistant Glioblastoma to the TGF-β Receptor Inhibitor.
Liu CC; Wu CL; Lin MX; Sze CI; Gean PW
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638842
[TBL] [Abstract][Full Text] [Related]
6. Effective treatment of glioblastoma requires crossing the blood-brain barrier and targeting tumors including cancer stem cells: The promise of nanomedicine.
Kim SS; Harford JB; Pirollo KF; Chang EH
Biochem Biophys Res Commun; 2015 Dec; 468(3):485-9. PubMed ID: 26116770
[TBL] [Abstract][Full Text] [Related]
7. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer stem cells for treatment of glioblastoma multiforme.
Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram: a novel repurposed drug for cancer therapy.
Lu C; Li X; Ren Y; Zhang X
Cancer Chemother Pharmacol; 2021 Feb; 87(2):159-172. PubMed ID: 33426580
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
Skaga E; Skaga IØ; Grieg Z; Sandberg CJ; Langmoen IA; Vik-Mo EO
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1495-1507. PubMed ID: 31028540
[TBL] [Abstract][Full Text] [Related]
11. Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.
Vengoji R; Ponnusamy MP; Rachagani S; Mahapatra S; Batra SK; Shonka N; Macha MA
Carcinogenesis; 2019 Mar; 40(1):2-14. PubMed ID: 30475990
[TBL] [Abstract][Full Text] [Related]
12. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
[TBL] [Abstract][Full Text] [Related]
13. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
[TBL] [Abstract][Full Text] [Related]
14. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells.
Hothi P; Martins TJ; Chen L; Deleyrolle L; Yoon JG; Reynolds B; Foltz G
Oncotarget; 2012 Oct; 3(10):1124-36. PubMed ID: 23165409
[TBL] [Abstract][Full Text] [Related]
15. Disulfiram repurposing combined with nutritional copper supplement as add-on to chemotherapy in recurrent glioblastoma (DIRECT): Study protocol for a randomized controlled trial.
Jakola AS; Werlenius K; Mudaisi M; Hylin S; Kinhult S; Bartek J; Salvesen Ø; Carlsen SM; Strandéus M; Lindskog M; Löfgren D; Rydenhag B; Carstam L; Gulati S; Solheim O; Bartek J; Solheim T
F1000Res; 2018; 7():1797. PubMed ID: 30647912
[No Abstract] [Full Text] [Related]
16. Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review).
Magrath JW; Kim Y
Int J Oncol; 2017 Sep; 51(3):753-759. PubMed ID: 28766685
[TBL] [Abstract][Full Text] [Related]
17. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
18. Brain tumor stem cells as research and treatment targets.
Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
[TBL] [Abstract][Full Text] [Related]
19. Elimination of cancer stem-like side population in human glioblastoma cells accompanied with stemness gene suppression by Korean herbal recipe MSC500.
Yao CJ; Han TY; Shih PH; Yi TY; Lai IC; Chang KH; Lai TY; Chang CL; Lai GM
Integr Cancer Ther; 2014 Nov; 13(6):541-54. PubMed ID: 25359730
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways.
Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J
Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
